Conversely, Xiao J. et al. observed that two patients exhibited positive PD-L1 expression for tumor cells, and one patient tested positive for immune cells, suggesting potential activation of the PD-1/PD-L1 pathway. This evidence concerns the gene CD274 and neoplasm.